Patent No. EP3338779 (titled "Tumor Therapeutic Agent") was filed by Eisai R&D Management on Aug 18, 2016. The application was issued on Jun 30, 2021.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
| Company | Opposition Date | Representative |
|---|---|---|
| STADA ARZNEIMITTEL | Mar 29, 2022 | HAMM & WITTKOPP |
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents
Aug 25, 2025
Aug 25, 2025
Aug 25, 2025
Jul 16, 2025
Jul 16, 2025
Jun 10, 2025
Jun 6, 2025
Jun 6, 2025
Jun 6, 2025
May 8, 2025
May 7, 2025
May 2, 2025
May 2, 2025
May 2, 2025
May 2, 2025
Apr 30, 2025
Apr 30, 2025
Apr 30, 2025
Apr 8, 2025
Apr 8, 2025
Feb 28, 2025
Feb 26, 2025
Feb 26, 2025
Feb 26, 2025
Feb 26, 2025
Feb 26, 2025
Oct 4, 2024
Sep 30, 2024
Jul 19, 2024
Jul 19, 2024
Jul 16, 2024
Jul 3, 2024
Jun 4, 2024
May 29, 2024
May 29, 2024
May 29, 2024
Feb 1, 2024
Jan 29, 2024
Jan 29, 2024
Jan 29, 2024
Dec 7, 2023
Dec 5, 2023
Dec 5, 2023
Dec 5, 2023
Dec 1, 2023
Dec 1, 2023
Nov 29, 2023
Nov 29, 2023
Nov 29, 2023
Oct 2, 2023
Oct 2, 2023
Sep 29, 2023
Sep 29, 2023
Sep 29, 2023
Sep 29, 2023
Sep 29, 2023
Sep 29, 2023
Sep 29, 2023
Sep 29, 2023
Sep 29, 2023
Sep 29, 2023
Sep 29, 2023
Sep 29, 2023
Sep 29, 2023
Sep 29, 2023
Sep 29, 2023
Sep 29, 2023
Sep 7, 2023
Jul 21, 2023
Jul 21, 2023
Jul 21, 2023
Jul 12, 2023
Jul 10, 2023
Jul 7, 2023
Jul 7, 2023
Jul 7, 2023
Jul 7, 2023
Jul 7, 2023
Jul 7, 2023
Jul 7, 2023
Jul 7, 2023
Jul 5, 2023
Jul 5, 2023
Jul 5, 2023
Jul 5, 2023
Jul 5, 2023
Jul 4, 2023
Jul 4, 2023
Jul 4, 2023
Feb 20, 2023
Feb 14, 2023
Feb 14, 2023
Feb 14, 2023
Feb 14, 2023
Feb 1, 2023
Jan 31, 2023
Jan 30, 2023
Jan 30, 2023
Jan 30, 2023
Jan 30, 2023
Jan 30, 2023
Jan 27, 2023
Jan 27, 2023
Jan 26, 2023
Jan 20, 2023
Jan 20, 2023
Jan 20, 2023
Jan 20, 2023
Jan 20, 2023
Jan 19, 2023
Jan 19, 2023
Jan 19, 2023
Jan 19, 2023
Jan 19, 2023
Jan 19, 2023
Jan 19, 2023
Aug 25, 2022
Aug 19, 2022
Aug 19, 2022
Aug 19, 2022
Aug 19, 2022
Aug 19, 2022
Aug 19, 2022
Aug 19, 2022
Aug 19, 2022
Aug 19, 2022
Aug 19, 2022
Aug 19, 2022
Apr 12, 2022
Apr 11, 2022
Apr 11, 2022
Apr 7, 2022
Apr 7, 2022
Apr 7, 2022
Apr 5, 2022
Mar 29, 2022
Mar 29, 2022
Mar 29, 2022
Mar 29, 2022
Mar 29, 2022
Mar 29, 2022
Mar 29, 2022
Mar 29, 2022
Mar 29, 2022
Mar 29, 2022
Jul 13, 2021
Jun 4, 2021
May 20, 2021
May 20, 2021
May 20, 2021
May 20, 2021
May 20, 2021
Feb 11, 2021
Feb 11, 2021
Feb 11, 2021
Feb 11, 2021
Feb 11, 2021
Aug 7, 2020
Aug 7, 2020
Aug 7, 2020
Aug 7, 2020
Aug 7, 2020
Apr 8, 2020
Apr 8, 2020
Apr 2, 2020
Aug 28, 2019
Aug 28, 2019
Aug 28, 2019
Aug 28, 2019
Apr 9, 2019
Mar 22, 2019
Mar 22, 2019
Mar 22, 2019
Mar 22, 2019
Mar 7, 2019
Sep 19, 2018
Sep 19, 2018
Sep 19, 2018
Sep 19, 2018
May 30, 2018
May 30, 2018
May 17, 2018
Mar 27, 2018
Mar 23, 2018
Mar 23, 2018
Mar 23, 2018
Mar 6, 2018
Mar 6, 2018
Feb 7, 2018
Feb 7, 2018
Feb 7, 2018
Feb 7, 2018
Feb 7, 2018
Jan 4, 2018
Mar 13, 2017
Feb 23, 2017
Feb 23, 2017
Feb 23, 2017